[Modification of the echographic pattern of carcinoma of the prostate treated with Lh-rh agonists].
We present the results of a study undertaken to assess the echo patterns and prostate size in 13 patients with prostatic carcinoma treated with Lh-rh agonists. The study revealed a gradual reduction of the anteroposterior and transverse diameters. After 12 months, these were 28% and 22% of their respective initial values. Furthermore, the prostatic echo patterns changed significantly in 66% of the patients, and infiltration of the seminal vesicle improved or became stable in 50%. These findings suggest that transrectal ultrasonography may be useful in the follow up of prostatic carcinoma patients receiving hormone therapy.
Broseta
E
E
Boronat
F
F
Domínguez
C
C
Vidal
J
J
Llopis
B
B
Jiménez-Cruz
J F
JF
D000368:Aged; D000369:Aged, 80 and over; D003534:Cyproterone / Q000031:analogs & derivatives / Q000627:therapeutic use*; D007987:Gonadotropin-Releasing Hormone / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011467:Prostate / Q000473:pathology*; D011471:Prostatic Neoplasms / Q000188:drug therapy / Q000473:pathology*; D014463:Ultrasonography
D007987:Gonadotropin-Releasing Hormone; D003534:Cyproterone
Modificación del patrón ecográfico del carcinoma de próstata tratado mediante agonistas Lh-rh.